Company intelligence / Profile preview

Orchid Holdings

Chennai, Tamil Nadu, Indiapohllc.com ↗

Ownership: Private
Development stage: Other

Overview

Orchid Pharma is a leading Indian pharmaceutical company specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It was the first Indian pharma firm to discover a new chemical entity—Enmetazobactam—now approved internationally. The company's main focus areas are anti-infectives, particularly cephalosporin antibiotics. After financial difficulties led to insolvency proceedings, it was acquired by Dhanuka Group in 2020 but remains an active commercial entity with global operations.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

Pfizer (historical for custom research/manufacturing services)Mayne Pharma/Hospira (historical for injectable antibiotic marketing)STADA Pharmaceuticals (historical for US/EU markets)Allecra Therapeutics (historical for novel antibiotic development)

Beyond the preview

Go deeper on Orchid Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orchid Holdings.

Explore the full profile